No Maspin expression in prostate tumor elicits host anti-tumor immunity

作者:Dzinic Sijana H; Chen Kang; Thakur Archana; Kaplun Alexander; Bonfil R Daniel; Li Xiaohua; Liu Jason; Bernardo M Margarida; Saliganan Allen; Back Jessica B; Yano Hiroshi; Schalk Dana L; Tomaszewski Elyse N; Beydoun Ahmed S; Dyson Gregory; Mujagic Adelina; Krass David; Dean Ivory; Mi Qing Sheng; Heath Elisabeth; Sakr Wael; Lum Lawrence G; Sheng Shijie*
来源:Oncotarget, 2014, 5(22): 11225-11236.

摘要

The goal of the current study is to examine the biological effects of epithelial-specific tumor suppressor maspin on tumor host immune response. Accumulated evidence demonstrates an anti-tumor effect of maspin on tumor growth, invasion and metastasis. The molecular mechanism underlying these biological functions of maspin is thought to be through histone deacetylase inhibition, key to the maintenance of differentiated epithelial phenotype. Since tumor-driven stromal reactivities co-evolve in tumor progression and metastasis, it is not surprising that maspin expression in tumor cells inhibits extracellular matrix degradation, increases fibrosis and blocks hypoxia-induced angiogenesis. Using the athymic nude mouse model capable of supporting the growth and progression of xenogeneic human prostate cancer cells, we further demonstrate that maspin expression in tumor cells elicits neutrophil- and B cells-dependent host tumor immunogenicity. Specifically, mice bearing maspin-expressing tumors exhibited increased systemic and intratumoral neutrophil maturation, activation and antibody-dependent cytotoxicity, and decreased peritumoral lymphangiogenesis. These results reveal a novel biological function of maspin in directing host immunity towards tumor elimination that helps explain the significant reduction of xenograft tumor incidence in vivo and the clinical correlation of maspin with better prognosis of several types of cancer. Taken together, our data raised the possibility for novel maspin-based cancer immunotherapies.

  • 出版日期2014-11-30
  • 单位NIH